124 related articles for article (PubMed ID: 31731183)
21. Generation and validation of PAX7 reporter lines from human iPS cells using CRISPR/Cas9 technology.
Wu J; Hunt SD; Xue H; Liu Y; Darabi R
Stem Cell Res; 2016 Mar; 16(2):220-8. PubMed ID: 26826926
[TBL] [Abstract][Full Text] [Related]
22. Sanfilippo Syndrome: Molecular Basis, Disease Models and Therapeutic Approaches.
Benetó N; Vilageliu L; Grinberg D; Canals I
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33105639
[TBL] [Abstract][Full Text] [Related]
23. Embryonic or Induced Pluripotent Stem Cell-Derived Hepatocellular Systems for HCV Culture.
Wu X; Dao Thi VL
Methods Mol Biol; 2019; 1911():121-135. PubMed ID: 30593622
[TBL] [Abstract][Full Text] [Related]
24. Generation of a gene corrected human isogenic iPSC line (CPGHi002-A-1) from a DDOD patient with heterozygous c.1516 C>T mutation in the ATP6V1B2 gene.
Gao X; Qiu SW; Wang WQ; Kang DY; Su N; Dai P; Yuan YY
Stem Cell Res; 2021 May; 53():102271. PubMed ID: 33714068
[TBL] [Abstract][Full Text] [Related]
25. Efficient CRISPR-Cas9-mediated generation of knockin human pluripotent stem cells lacking undesired mutations at the targeted locus.
Merkle FT; Neuhausser WM; Santos D; Valen E; Gagnon JA; Maas K; Sandoe J; Schier AF; Eggan K
Cell Rep; 2015 May; 11(6):875-883. PubMed ID: 25937281
[TBL] [Abstract][Full Text] [Related]
26. Generation of heterozygous SAMD9 CRISPR/Cas9-edited iPSC line (ESi086-A-3), carrying p.I1567M mutation.
Pera J; Castaño J; Casamitjana J; Giorgetti A; Romero-Moya D
Stem Cell Res; 2022 Oct; 64():102906. PubMed ID: 36087523
[TBL] [Abstract][Full Text] [Related]
27. Generation of gene-corrected human induced pluripotent stem cell lines derived from retinitis pigmentosa patient with Ser331Cysfs*5 mutation in MERTK.
Artero Castro A; Long K; Bassett A; Machuca C; León M; Ávila-Fernandez A; Cortón M; Vidal-Puig T; Ayuso C; Lukovic D; Erceg S
Stem Cell Res; 2019 Jan; 34():101341. PubMed ID: 30612079
[TBL] [Abstract][Full Text] [Related]
28. Both TALENs and CRISPR/Cas9 directly target the HBB IVS2-654 (C > T) mutation in β-thalassemia-derived iPSCs.
Xu P; Tong Y; Liu XZ; Wang TT; Cheng L; Wang BY; Lv X; Huang Y; Liu DP
Sci Rep; 2015 Jul; 5():12065. PubMed ID: 26156589
[TBL] [Abstract][Full Text] [Related]
29. Induced Pluripotent Stem Cells Meet Genome Editing.
Hockemeyer D; Jaenisch R
Cell Stem Cell; 2016 May; 18(5):573-86. PubMed ID: 27152442
[TBL] [Abstract][Full Text] [Related]
30. Generation of two induced pluripotent stem cells lines from Mucopolysaccharydosis IIIA patient: IMEDEAi004-A and IMEDEAi004-B.
Vallejo S; Fleischer A; Martín JM; Sánchez A; Palomino E; Bachiller D
Stem Cell Res; 2018 Oct; 32():110-114. PubMed ID: 30269021
[TBL] [Abstract][Full Text] [Related]
31. Sanfilippo syndrome type C: assay for acetyl-CoA: alpha-glucosaminide N-acetyltransferase in leukocytes for detection of homozygous and heterozygous individuals.
Klein U; van de Kamp JJ; von Figura K; Pohlmann R
Clin Genet; 1981 Jul; 20(1):55-9. PubMed ID: 6794963
[TBL] [Abstract][Full Text] [Related]
32. Generation of three human induced pluripotent stem cell lines with IRX5 knockout and knockin genetic editions using CRISPR-Cas9 system.
Canac R; Caillaud A; Cimarosti B; Girardeau A; Hamamy H; Reversade B; Bonnard C; Al Sayed ZR; David L; Poschmann J; Lemarchand P; Lamirault G; Gaborit N
Stem Cell Res; 2022 Jan; 58():102627. PubMed ID: 34929443
[TBL] [Abstract][Full Text] [Related]
33. Generation of a TLE3 heterozygous knockout human embryonic stem cell line using CRISPR-Cas9.
Bara AM; Messana A; Herring A; Hazelbaker DZ; Eggan K; Barrett LE
Stem Cell Res; 2016 Sep; 17(2):441-443. PubMed ID: 27879221
[TBL] [Abstract][Full Text] [Related]
34. Application of CRISPR/Cas9 to the study of brain development and neuropsychiatric disease.
Powell SK; Gregory J; Akbarian S; Brennand KJ
Mol Cell Neurosci; 2017 Jul; 82():157-166. PubMed ID: 28549865
[TBL] [Abstract][Full Text] [Related]
35. Generation of a TLR7 homozygous knockout human induced pluripotent stem cell line using CRISPR/Cas9.
Han HJ; Seo HH; Han HW; Kim JH
Stem Cell Res; 2019 Oct; 40():101520. PubMed ID: 31445394
[TBL] [Abstract][Full Text] [Related]
36. Generation of a GDE heterozygous mutation human embryonic stem cell line WAe001-A-14 by CRISPR/Cas9 editing.
Xu G; Guo D; Wu F; Abbas N; Lai K; Yuan F; You K; Liu Y; Zhuang Y; Wu Y; Xu Y; Chen Y; Yang F; Pan T; Li YX
Stem Cell Res; 2018 Mar; 27():38-41. PubMed ID: 29310060
[TBL] [Abstract][Full Text] [Related]
37. Targeted gene therapy in human-induced pluripotent stem cells from a patient with primary hyperoxaluria type 1 using CRISPR/Cas9 technology.
Estève J; Blouin JM; Lalanne M; Azzi-Martin L; Dubus P; Bidet A; Harambat J; Llanas B; Moranvillier I; Bedel A; Moreau-Gaudry F; Richard E
Biochem Biophys Res Commun; 2019 Oct; 517(4):677-683. PubMed ID: 31402115
[TBL] [Abstract][Full Text] [Related]
38. Activity and High-Order Effective Connectivity Alterations in Sanfilippo C Patient-Specific Neuronal Networks.
Canals I; Soriano J; Orlandi JG; Torrent R; Richaud-Patin Y; Jiménez-Delgado S; Merlin S; Follenzi A; Consiglio A; Vilageliu L; Grinberg D; Raya A
Stem Cell Reports; 2015 Oct; 5(4):546-57. PubMed ID: 26411903
[TBL] [Abstract][Full Text] [Related]
39. Human Induced Pluripotent Stem Cell NEUROG2 Dual Knockin Reporter Lines Generated by the CRISPR/Cas9 System.
Li S; Xue H; Wu J; Rao MS; Kim DH; Deng W; Liu Y
Stem Cells Dev; 2015 Dec; 24(24):2925-42. PubMed ID: 26414932
[TBL] [Abstract][Full Text] [Related]
40. A high-throughput screening strategy for detecting CRISPR-Cas9 induced mutations using next-generation sequencing.
Bell CC; Magor GW; Gillinder KR; Perkins AC
BMC Genomics; 2014 Nov; 15(1):1002. PubMed ID: 25409780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
